logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Dissanayake, Sanjeeva, Dr
    Born in July 1968
    Individual (3 offsprings)
    Officer
    2019-11-22 ~ now
    OF - Director → CIF 0
    Dr Sanjeeva Dissanayake
    Born in July 1968
    Individual (3 offsprings)
    Person with significant control
    2019-11-22 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
  • 2
    Mr Zarni Win
    Born in April 1970
    Individual (3 offsprings)
    Person with significant control
    2020-09-04 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

SENARI PHARMA LTD

Period: 2019-11-22 ~ now
Company number: 12329134
Registered name
SENARI PHARMA LTD - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
12024-02-01 ~ 2025-01-31
12023-02-01 ~ 2024-01-31
Debtors
27,136 GBP2025-01-31
26,568 GBP2024-01-31
Cash at bank and in hand
1,878 GBP2025-01-31
385 GBP2024-01-31
Current Assets
29,014 GBP2025-01-31
26,953 GBP2024-01-31
Creditors
Amounts falling due within one year
206,264 GBP2025-01-31
147,323 GBP2024-01-31
Net Current Assets/Liabilities
177,250 GBP2025-01-31
120,370 GBP2024-01-31
Total Assets Less Current Liabilities
-177,250 GBP2025-01-31
-120,370 GBP2024-01-31
Net Assets/Liabilities
-177,250 GBP2025-01-31
-120,370 GBP2024-01-31
Equity
Called up share capital
169 GBP2025-01-31
155 GBP2024-01-31
Share premium
535,956 GBP2025-01-31
535,956 GBP2024-01-31
Retained earnings (accumulated losses)
-713,375 GBP2025-01-31
-656,481 GBP2024-01-31
Equity
-177,250 GBP2025-01-31
-120,370 GBP2024-01-31
Other Debtors
27,136 GBP2025-01-31
26,568 GBP2024-01-31
Trade Creditors/Trade Payables
Amounts falling due within one year
11,777 GBP2025-01-31
3,199 GBP2024-01-31
Other Creditors
Amounts falling due within one year
194,487 GBP2025-01-31
144,124 GBP2024-01-31

  • SENARI PHARMA LTD
    Info
    Registered number 12329134
    71-75 Shelton Street, Covent Garden, London WC2H 9JQ
    PRIVATE LIMITED COMPANY incorporated on 2019-11-22 (6 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-06-10
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.